Song Jin Soo Andy, Taylor S Mark, Trites Jonathan, Rigby Matthew H, Bullock Martin Joseph, Merrimen Jennifer, Rendon Ricardo, Hart Robert D
Division of Otolaryngology-Head & Neck Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
J Otolaryngol Head Neck Surg. 2017 Mar 1;46(1):17. doi: 10.1186/s40463-017-0193-3.
Thyroid metastases to distant sites are uncommon incidents, most often metastasizing to the lungs and bones. Rates of metastasis to the kidney are particularly low, ranging from 2.8-3.8% for papillary and 6-20% for follicular variants of well-differentiated thyroid cancers (WDTCs). In rare instances, tumor-to-tumor metastasis between two true primary neoplasms can occurs. This medical phenomenon has previously occurred as a clear cell renal cell carcinoma (CCRCC) spreading to a WDTC. To our knowledge, this is the first report of a tumor-to-tumor metastasis of a thyroid cancer metastasizing to a primary renal neoplasm.
A 72 year old male presented to the urology clinic with complaints of flank pain. Computed tomography (CT) imaging of the abdomen and pelvis revealed a 5.7 cm solid enhancing mass from the lateral aspect of the right kidney, suspicious for renal cell carcinoma (RCC). The patient subsequently underwent a right laparoscopic radical nephrectomy, and immunohistochemical staining of the 5.5 cm lesion revealed a positive RCC marker to establish a diagnosis of a pT1b ISUP Grade 2 CCRCC. The tumor contained a 3 mm focus of a lesion staining positive for TTF1 and Thyroglobulin, and negative for RCC marker. This finding established a diagnosis of a tumor-to-tumor metastasis of PTC to CCRCC. Subsequent ultrasound and CT of the head and neck revealed a heterogeneously hypodense 3.3 cm mass in the right thyroid lobe, prompting a total thyroidectomy and level VI neck dissection. Pathology revealed a classic variant multifocal PTC and two ipsilateral lymph nodes positive for metastatic PTC. Ultimately, the thyroid specimen was positive for lymphatic vascular invasion, extrathyroidal extension with invasion of the tracheal cartilage, staging as T4aN1aM1. On follow up examination the patient was recovering well, without signs of dysphagia or dysphonia, and showed bilateral mobile vocal cords on laryngoscope examination.
Tumor-to-tumor metastasis between the thyroid and kidney is an extremely rare occurrence, reports of RCC metastases from a WDTC has not yet been reported in the literature. Corroboration of diagnostic imaging findings with immunohistochemistry staining can consolidate a diagnosis of thyroid neoplasm tumor-to-tumor metastasis to a RCC, thereby prompting surgical excision.
甲状腺远处转移并不常见,最常转移至肺和骨骼。转移至肾脏的发生率尤其低,分化型甲状腺癌(WDTC)的乳头状亚型转移至肾脏的发生率为2.8%-3.8%,滤泡状亚型为6%-20%。在罕见情况下,两个真正的原发性肿瘤之间可发生肿瘤-to-肿瘤转移。这种医学现象此前曾表现为透明细胞肾细胞癌(CCRCC)转移至WDTC。据我们所知,这是甲状腺癌转移至原发性肾肿瘤的肿瘤-to-肿瘤转移的首例报告。
一名72岁男性因侧腹痛就诊于泌尿外科门诊。腹部和盆腔的计算机断层扫描(CT)成像显示右肾外侧有一个5.7cm的实性强化肿块,怀疑为肾细胞癌(RCC)。患者随后接受了右侧腹腔镜根治性肾切除术,对5.5cm病变进行免疫组化染色显示RCC标志物呈阳性,从而确诊为pT1b ISUP 2级CCRCC。肿瘤内有一个3mm的病灶,TTF1和甲状腺球蛋白染色呈阳性,RCC标志物染色呈阴性。这一发现确诊为PTC至CCRCC的肿瘤-to-肿瘤转移。随后对头颈部进行的超声和CT检查显示右甲状腺叶有一个3.3cm的不均匀低密度肿块,促使进行了全甲状腺切除术和VI区颈部淋巴结清扫术。病理显示为经典型多灶性PTC,两个同侧淋巴结有转移性PTC阳性。最终,甲状腺标本有淋巴管侵犯、甲状腺外侵犯并侵犯气管软骨,分期为T4aN1aM1。在后续检查中,患者恢复良好,无吞咽困难或声音嘶哑迹象,喉镜检查显示双侧声带活动正常。
甲状腺和肾脏之间的肿瘤-to-肿瘤转移极为罕见,WDTC转移至RCC的报告在文献中尚未见报道。诊断性影像学检查结果与免疫组化染色相结合可巩固甲状腺肿瘤-to-肿瘤转移至RCC的诊断,从而促使进行手术切除。